Real World Evidence Solution
SKU
MRR-035AB9C0DA82
Region
Global
Publication Date
January 2024
Delivery
Immediate
2022
USD 1.21 billion
2030
USD 3.47 billion
2023
USD 1.38 billion
CAGR
13.99%
Real World Evidence Solution Market by Component (Data Set, Services), Therapeutic Area (Cardiovascular, Immunology, Infectious Diseases), End-User - Global Forecast 2023-2030

[186 Pages Report] The Real World Evidence Solution Market size was estimated at USD 1.21 billion in 2022 and expected to reach USD 1.38 billion in 2023, at a CAGR 13.99% to reach USD 3.47 billion by 2030.

Real World Evidence Solution Market
To learn more about this report, request a free sample copy

The real world evidence (RWE) solutions enable healthcare organizations, government agencies, and pharmaceutical companies to analyze and utilize real-world data. This data, which includes information collected outside of traditional clinical trials such as electronic health records (EHR), insurance claims, patient registries, and mobile devices, is proving to be invaluable for understanding the effectiveness, safety, and value of healthcare interventions in day-to-day clinical practice. The rise in R&D by pharmaceutical companies has led to an increase in the adoption of RWE solutions for cost-effective drug development and shorter time-to-market. Regulatory bodies are increasingly acknowledging the value of RWE in understanding post-market drug and device usage, which encourages market growth. The growing healthcare industry's shift towards value-based care has promoted the use of RWE solutions to demonstrate the effectiveness of treatments. Data privacy & security concerns with real world evidence (RWE) solutions hampers the growth of the market. Developing advanced analytical models and algorithms to extract meaningful insights from diverse and large datasets and creating user-friendly platforms that accommodate complex needs are expected to create a platform for market growth.

Real World Evidence Solution Market - Global Forecast 2023-2030
To learn more about this report, request a free sample copy
Component: Growing usage of data set within real world evidence solutions to generate real-world evidence (RWE)

In real-world evidence solutions, the data set component refers to the collection of real-world data (RWD) that can be used to generate real-world evidence (RWE). These data sets are derived from various sources such as claims and billing activities, electronic health records (EHRs), product and disease registries, patient-generated data including in-home-use settings, and data gathered from sources that can inform on health status, such as mobile devices. The services component of real-world evidence solutions encompasses the various offerings provided by solution providers to assist clients in generating and leveraging real-world evidence. Services can range from data analytics and processing to consultation on the design and implementation of real-world studies. Additional services may include regulatory support to ensure compliance with applicable guidelines, advanced analytics, data interpretation, and strategic planning.

End-User: Rising potential of real-world evidence solutions across biopharmaceutical companies to support drug development

Biopharmaceutical companies leverage RWE solutions to support drug development, market access strategies, and post-market surveillance. They need solutions that provide insights into patient outcomes, health economics, and epidemiology. RWE is pivotal in demonstrating the value of drugs to regulators, payers, and healthcare providers. These companies prefer robust data analytics platforms that can handle large datasets from claims data, electronic health records (EHR), and patient registries. Clinical and life sciences organizations such as contract research organizations (CROs) and academic institutions use RWE to validate clinical trial outcomes and to understand disease progression and treatment pathways further. These users value RWE for its ability to identify patient cohorts, enhance recruitment for clinical trials, and establish more effective and cost-efficient treatment protocols. They also look for technologies that can create real-time connections between clinical study data and real-world patient data. Diagnostics & medical device companies are increasingly adopting RWE for product development and market differentiation. For these companies, RWE can inform the design and utility of diagnostics tests and devices, monitor post-marketing safety, and support reimbursement and health technology assessment (HTA) applications. They prioritize solutions that can demonstrate clinical effectiveness and real-world usability and offer comparative analyses against existing standards of care.

Regional Insights

In the Americas, the RWE solutions market is expanding with the growing healthcare reform initiatives that fuel demand to leverage RWE for enhanced decision-making. The Americas has seen a surge in patent filings related to advanced data analytics and AI in healthcare. Investment in digital health technologies continues to climb, reflecting the region's pursuit of innovation in healthcare delivery. In the European Union, the adoption of RWE solutions is heterogeneous, with some countries showing more advancement than others. The Euro-centric focus on cost-effectiveness and budget impact for healthcare interventions drives the demand for RWE. The Middle East and Africa showcase a diverse and emerging market for RWE solutions, where healthcare infrastructure and regulatory frameworks are developing at an uneven pace. The Asia Pacific region is a vibrant and fast-growing market for RWE solutions, with countries such as China, Japan, and India playing significant roles. China's latest five-year plan includes a substantial emphasis on healthcare and biotech, showcasing a commitment to invest in digital health and RWE generation. Japan's focus on healthcare innovation is evident in state-funded initiatives aimed at integrating RWE into healthcare delivery and pharmaceutical regulation. In India, increasing digitalization, government initiatives towards universal health coverage, and a growing pharmaceutical sector contribute to the RWE landscape.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Real World Evidence Solution Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Real World Evidence Solution Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Maxis Clinical Sciences Launches Real-World Evidence Solutions Service

    Maxis Clinical Sciences launched an innovative Real-World Evidence (RWE) Solutions service that is set to transform the landscape of patient care and clinical studies by seamlessly capturing and unifying Real-World Data (RWD) from a vast array of patient populations and sources for thorough analysis. The company's dedicated commitment lies in diminishing the divide between clinical research initiatives and the forefront of digital advancement, all while prioritizing patient-oriented approaches. The comprehensive RWE Solutions created by Maxis Clinical Sciences are expressly designed to incorporate an extensive range of RWD inputs, including insightful patient-reported outcomes and metrics obtained from wearable technology. [Published On: 2023-10-21]

  • Target RWE's Cutting-Edge Analytical Solutions Launched to Propel Real-World Evidence Generation

    Target RWE announced the introduction of its cutting-edge suite of analytical solutions. Tailored to meet the pressing needs within pharmaceutical product life cycles, these solutions employ advanced epidemiological approaches and robust statistical frameworks to uncover unmet demands and address key strategic queries. Target RWE's latest offerings are powered by an innovative, proprietary analytical platform integral to its Syndicated Science Insights (SSI) solutions, which tackle research hypotheses across varied data sources, including claims and electronic health records. [Published On: 2023-08-23]

  • Verana Health Launches Real-World Evidence-Driven Solution for Clinical Trial Site Selection

    Verana Health unveiled VeraSite, a groundbreaking subscription-based platform designed to streamline the clinical trial site selection process. VeraSite equips trial sponsors and contract research organizations (CROs) with a powerful tool to swiftly identify medical practices that have both clinical proficiency and suitable patient demographics for specific clinical trial protocols. This innovative solution facilitates more aligned site selection, optimizing trial outcomes. Acknowledging the importance of direct communication, VeraSite enables sponsors to contact consenting practices directly, fostering collaboration between researchers and potential trial sites. [Published On: 2023-06-22]

Key Company Profiles

The report delves into recent significant developments in the Real World Evidence Solution Market, highlighting leading vendors and their innovative profiles. These include Aetion, Inc., Cardinal Health, Inc., Certara, L.P., Clinerion Ltd, Clinixir Company Limited, Cognizant Technology Solutions Corp., COREVITAS, LLC., Flatiron Health, Inc., ICON PLC, International Business Machines Corporation, IQVIA Inc., ISPOR, Laboratory Corporation of America Holdings, Mercy Technology Services, Optum, Inc., Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., Pharmaceutical Product Development, LLC by Thermo Fisher Scientific Inc., Quantzig, SAS Institute, Inc., Syneos Health, TATA Consultancy Services Limited, Turacoz, and United BioSource LLC.

Market Segmentation & Coverage

This research report categorizes the Real World Evidence Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Data Set
      • Claims Data
      • Clinical Settings Data
      • Patient-Powered Data
      • Pharmacy Data
    • Services
  • Therapeutic Area
    • Cardiovascular
    • Immunology
    • Infectious Diseases
    • Neurology
    • Oncology
  • End-User
    • Biopharmaceutical Company
    • Clinical & Life Sciences Organization
    • Diagnostics or Medical Device Company

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Real World Evidence Solution Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Real World Evidence Solution Market?
  3. What are the technology trends and regulatory frameworks in the Real World Evidence Solution Market?
  4. What is the market share of the leading vendors in the Real World Evidence Solution Market?
  5. Which modes and strategic moves are suitable for entering the Real World Evidence Solution Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageREAL WORLD EVIDENCE SOLUTION MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. REAL WORLD EVIDENCE SOLUTION MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2022 VS 2030
  4. Market Overview
    1. IntroductionREAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
    2. Real World Evidence Solution Market, by RegionREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsREAL WORLD EVIDENCE SOLUTION MARKET DYNAMICS
      1. Drivers
        1. Shift from volume to value based care
        2. Delays in drug development and the subsequent increase in development costs
        3. Drug safety and effectiveness after clinical trials
      2. Restraints
        1. Reluctance to rely on real-world studies
      3. Opportunities
        1. Rising focus on end-to-end RWE services
        2. Emerging roles of wearable devices and AI in RWE
      4. Challenges
        1. Lack of universally accepted methodological standards and data processing infrastructure
    2. Market Segmentation Analysis
      1. Component: Growing usage of data set within real world evidence solutions to generate real-world evidence (RWE)
      2. End-User: Rising potential of real-world evidence solutions across biopharmaceutical companies to support drug development
    3. Market Trend Analysis
    4. Cumulative Impact of COVID-19
    5. Cumulative Impact of Russia-Ukraine Conflict
    6. Cumulative Impact of High Inflation
    7. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    8. Value Chain & Critical Path Analysis
    9. Regulatory Framework
    10. Client Customization
  6. Real World Evidence Solution Market, by Component
    1. IntroductionREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
    2. Data SetREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY , 2018-2030 (USD MILLION)
    3. REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)
      1. Claims DataREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY , 2018-2030 (USD MILLION)
      2. Clinical Settings DataREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY , 2018-2030 (USD MILLION)
      3. Patient-Powered DataREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY , 2018-2030 (USD MILLION)
      4. Pharmacy DataREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY , 2018-2030 (USD MILLION)
    4. ServicesREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY , 2018-2030 (USD MILLION)
  7. Real World Evidence Solution Market, by Therapeutic Area
    1. IntroductionREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
    2. CardiovascularREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY , 2018-2030 (USD MILLION)
    3. ImmunologyREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY , 2018-2030 (USD MILLION)
    4. Infectious DiseasesREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY , 2018-2030 (USD MILLION)
    5. NeurologyREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY , 2018-2030 (USD MILLION)
    6. OncologyREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY , 2018-2030 (USD MILLION)
  8. Real World Evidence Solution Market, by End-User
    1. IntroductionREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    2. Biopharmaceutical CompanyREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY , 2018-2030 (USD MILLION)
    3. Clinical & Life Sciences OrganizationREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY , 2018-2030 (USD MILLION)
    4. Diagnostics or Medical Device CompanyREAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY , 2018-2030 (USD MILLION)
  9. Americas Real World Evidence Solution Market
    1. Introduction
    2. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY STATE, 2022 VS 2030 (%)UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  10. Asia-Pacific Real World Evidence Solution Market
    1. Introduction
    2. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. China
    7. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. India
    9. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)SINGAPORE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)SINGAPORE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)SINGAPORE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)TAIWAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)TAIWAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)TAIWAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)VIETNAM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)VIETNAM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)VIETNAM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  11. Europe, Middle East & Africa Real World Evidence Solution Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)DENMARK REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)DENMARK REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)DENMARK REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)EGYPT REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)EGYPT REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)EGYPT REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)FINLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)FINLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)FINLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)ISRAEL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)ISRAEL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)ISRAEL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)NIGERIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)NIGERIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)NIGERIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)NORWAY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)NORWAY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)NORWAY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)POLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)POLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)POLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)SWEDEN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)SWEDEN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)SWEDEN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)SWITZERLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)SWITZERLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)SWITZERLAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)TURKEY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)TURKEY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)TURKEY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2030 (USD MILLION)UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  12. Competitive Landscape
    1. FPNV Positioning MatrixREAL WORLD EVIDENCE SOLUTION MARKET, FPNV POSITIONING MATRIX, 2022REAL WORLD EVIDENCE SOLUTION MARKET, FPNV POSITIONING MATRIX, 2022
    2. Market Share Analysis, By Key PlayerREAL WORLD EVIDENCE SOLUTION MARKET SHARE, BY KEY PLAYER, 2022REAL WORLD EVIDENCE SOLUTION MARKET SHARE, BY KEY PLAYER, 2022
    3. Competitive Scenario Analysis, By Key Player
      1. Maxis Clinical Sciences Launches Real-World Evidence Solutions Service
      2. Target RWE's Cutting-Edge Analytical Solutions Launched to Propel Real-World Evidence Generation
      3. Verana Health Launches Real-World Evidence-Driven Solution for Clinical Trial Site Selection
  13. Competitive Portfolio
    1. Key Company Profiles
      1. Aetion, Inc.
      2. Cardinal Health, Inc.
      3. Certara, L.P.
      4. Clinerion Ltd
      5. Clinixir Company Limited
      6. Cognizant Technology Solutions Corp.
      7. COREVITAS, LLC.
      8. Flatiron Health, Inc.
      9. ICON PLC
      10. International Business Machines Corporation
      11. IQVIA Inc.
      12. ISPOR
      13. Laboratory Corporation of America Holdings
      14. Mercy Technology Services
      15. Optum, Inc.
      16. Oracle Corporation
      17. PAREXEL International Corporation
      18. PerkinElmer Inc.
      19. Pharmaceutical Product Development, LLC by Thermo Fisher Scientific Inc.
      20. Quantzig
      21. SAS Institute, Inc.
      22. Syneos Health
      23. TATA Consultancy Services Limited
      24. Turacoz
      25. United BioSource LLC
    2. Key Product Portfolio
  1. Aetion, Inc.
  2. Cardinal Health, Inc.
  3. Certara, L.P.
  4. Clinerion Ltd
  5. Clinixir Company Limited
  6. Cognizant Technology Solutions Corp.
  7. COREVITAS, LLC.
  8. Flatiron Health, Inc.
  9. ICON PLC
  10. International Business Machines Corporation
  11. IQVIA Inc.
  12. ISPOR
  13. Laboratory Corporation of America Holdings
  14. Mercy Technology Services
  15. Optum, Inc.
  16. Oracle Corporation
  17. PAREXEL International Corporation
  18. PerkinElmer Inc.
  19. Pharmaceutical Product Development, LLC by Thermo Fisher Scientific Inc.
  20. Quantzig
  21. SAS Institute, Inc.
  22. Syneos Health
  23. TATA Consultancy Services Limited
  24. Turacoz
  25. United BioSource LLC
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Real World Evidence Solution Market
The Global Real World Evidence Solution Market size was estimated at USD 1.21 billion in 2022 and expected to reach USD 1.38 billion in 2023.
The Global Real World Evidence Solution Market to grow USD 3.47 billion by 2030, at a CAGR of 13.99%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.